Who owns ASPIRE BIOPHARMA HLDGS INC?
- Ticker: ASBP
- CUSIP Number: 738920107
Tip: Access positions for across all investors
Analyze quarterly positions in Aspire Biopharma Hldgs with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Aspire Biopharma Hldgs stock
Who bought or sold ASPIRE BIOPHARMA HLDGS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Crossingbridge Advisors | 24k | $7.4k | 0% | Mar 2026 |
|
| Hallmark Capital Management | 1.0k | $1.0k | -98% | Mar 2026 |
|
Who sold out of Aspire Biopharma Hldgs?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| UBS Group | Dec 2025 | 2.5M | $332k |
| Crewe Advisors | Dec 2025 | 813k | $107k |
| Jane Street | Dec 2025 | 688k | $91k |
| Optivise Advisory Services | Dec 2025 | 357k | $47k |
| XTX Topco | Dec 2025 | 266k | $35k |
| Geode Capital Management | Dec 2025 | 248k | $33k |
| Resolute Advisors | Dec 2025 | 156k | $21k |
| Three Seasons Wealth | Dec 2025 | 125k | $17k |
| Virtu Financial | Dec 2025 | 109k | $14k |
| Verition Fund Management | Dec 2025 | 97k | $13k |
| VR Advisory Services | Dec 2025 | 97k | $13k |
| EP Wealth Advisors | Dec 2025 | 63k | $8.3k |
| P. Schoenfeld Asset Management | Dec 2025 | 59k | $7.7k |
| Efficient Wealth Management | Dec 2025 | 54k | $7.0k |
| Scientech Research | Dec 2025 | 52k | $6.8k |
| Periscope Capital | Dec 2025 | 50k | $6.6k |
| Platform Technology Partners | Dec 2025 | 38k | $5.0k |
| Intl Fcstone | Dec 2025 | 15k | $1.9k |
| Point72 Asset Management | Dec 2025 | 14k | $1.9k |
| Allred Capital Management | Dec 2025 | 11k | $1.5k |
| Fisher Investments | Dec 2025 | 10k | $1.3k |
| Tower Research Capital | Dec 2025 | 9.6k | $1.3k |